WO2019155266A8 - Flavocillin: a new penicillin derivative - Google Patents

Flavocillin: a new penicillin derivative Download PDF

Info

Publication number
WO2019155266A8
WO2019155266A8 PCT/IB2018/050851 IB2018050851W WO2019155266A8 WO 2019155266 A8 WO2019155266 A8 WO 2019155266A8 IB 2018050851 W IB2018050851 W IB 2018050851W WO 2019155266 A8 WO2019155266 A8 WO 2019155266A8
Authority
WO
WIPO (PCT)
Prior art keywords
antibiotic
flavocilin
flavocillin
penicillin derivative
new penicillin
Prior art date
Application number
PCT/IB2018/050851
Other languages
French (fr)
Other versions
WO2019155266A1 (en
Inventor
Mustafa Pehlivan
Original Assignee
Mustafa Pehlivan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mustafa Pehlivan filed Critical Mustafa Pehlivan
Priority to PCT/IB2018/050851 priority Critical patent/WO2019155266A1/en
Priority to EP18713342.6A priority patent/EP3752509A1/en
Publication of WO2019155266A1 publication Critical patent/WO2019155266A1/en
Publication of WO2019155266A8 publication Critical patent/WO2019155266A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/74—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with carbocyclic rings directly attached to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

This invention is about the discovery of a new novel compound as an antibiotic to stop this potential resistance problem completely. With Organic Chemistry studies and methods and other modified antibiotics, adding a flavonoid group to varibale side R instead which will result in flavocilin formation will be the most effective and revolutionary antibiotic that the bacteria will never be able to resist. Evidentful pathways have been conculded stating that the Flavocilin use in Medicine for heavy infectious conditions or where no other antibiotic works will outweigh all its risks.
PCT/IB2018/050851 2018-02-12 2018-02-12 Flavocillin: a new novel antibitoic that the bacteria will never develop WO2019155266A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2018/050851 WO2019155266A1 (en) 2018-02-12 2018-02-12 Flavocillin: a new novel antibitoic that the bacteria will never develop
EP18713342.6A EP3752509A1 (en) 2018-02-12 2018-02-12 Flavocillin: a new penicillin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2018/050851 WO2019155266A1 (en) 2018-02-12 2018-02-12 Flavocillin: a new novel antibitoic that the bacteria will never develop

Publications (2)

Publication Number Publication Date
WO2019155266A1 WO2019155266A1 (en) 2019-08-15
WO2019155266A8 true WO2019155266A8 (en) 2020-06-18

Family

ID=61768349

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2018/050851 WO2019155266A1 (en) 2018-02-12 2018-02-12 Flavocillin: a new novel antibitoic that the bacteria will never develop

Country Status (2)

Country Link
EP (1) EP3752509A1 (en)
WO (1) WO2019155266A1 (en)

Also Published As

Publication number Publication date
WO2019155266A1 (en) 2019-08-15
EP3752509A1 (en) 2020-12-23

Similar Documents

Publication Publication Date Title
AU2019264537A1 (en) Beta-lactamase inhibitors
WO2013122888A3 (en) Methods of treating bacterial infections
EA201991523A1 (en) COMBINED THERAPY BY AMIDINE-SUBSTITUTED BETA-LACTAMIC COMPOUNDS AND INHIBITORS OF BETA-LACTAMASE IN INFECTIONS CAUSED BY BACTERIAL STRAINS RESISTANT TO ANTIBIOTICS
AU2012302022A8 (en) Antibacterial compounds and methods for use
BR112016010082A2 (en) fungal endophytes to improve crop yield and pest protection
WO2015003816A3 (en) Cystobactamides
NZ617104A (en) Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
EP3691639A4 (en) Chromane monobactam compounds for the treatment of bacterial infections
AU2015352440B2 (en) Compounds
WO2015024010A3 (en) Substituted hydroxamic acid compounds
EP4234554A3 (en) Crystalline solid forms of a bet inhibitor
WO2011019839A3 (en) Glycopeptide and lipoglycopeptide antibiotics with improved solubility
PH12016501988A1 (en) Antibacterial compounds
EP3448522A4 (en) Novel substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase
EP4268897A3 (en) Minocycline compounds for biodefense
WO2017218922A8 (en) Compositions and methods for the treatment of bacterial infections
PH12017502319A1 (en) Injectable pharmaceutical formulations of lefamulin
PH12018500202B1 (en) New effective aminoglycoside antibiotic for multidrug-resistant bacteria
EP3592349A4 (en) Administration of antibiotic compounds for the treatment of streptococcal infections for the treatment of psoriasis
MX2021001564A (en) Diazabicyclooctanones as inhibitors of serine beta-lactamases.
EP3750881A4 (en) Compound acting as antibiotics
CL2016000672A1 (en) Isolated bacterium of the genus streptomyces
WO2015024021A3 (en) Antibacterial compounds
NZ706734A (en) Pharmaceutical compositions useful for the treatment or control of bacterial infections
WO2016055800A3 (en) Fluorescent synthetic retinoids

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18713342

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018713342

Country of ref document: EP

Effective date: 20200914